Hematology/Oncology policy updates
Track new and updated Hematology/Oncology policies impacting reimbursement and clinical operations.
| Policy | Payer | Type | Specialty | Change | Effective |
|---|---|---|---|---|---|
| Narsoplimab-wuug (Yartemlea) — Coverage Criteria for TA-TMA | Blue Cross Blue Shield - North Carolina | Clinical | Hematology/Oncology | Modified | May 1, 2026 |
| CAR T-cell therapy (listed products) — coverage criteria | Blue Cross Blue Shield - North Carolina | Clinical | Hematology/Oncology | Modified | Apr 1, 2026 |
| Afamitresgene autoleucel (Tecelra) — Coverage Criteria | Blue Cross Blue Shield - North Carolina | Clinical | Hematology/Oncology | Modified | Apr 1, 2026 |
| Betibeglogene autotemcel (Zynteglo) — Coverage Criteria for Transfusion-Dependent Beta-Thalassemia | Blue Cross Blue Shield - North Carolina | Clinical | Hematology/Oncology | Modified | Apr 1, 2026 |
| Etranacogene dezaparvovec-drlb (Hemgenix) — Coverage Criteria (intravenous gene therapy for hemophilia B) | Blue Cross Blue Shield - North Carolina | Clinical | Hematology/Oncology | Modified | Apr 1, 2026 |
| Exagamglogene autotemcel (Casgevy®) 'Notification' | Blue Cross Blue Shield - North Carolina | Clinical | Hematology/Oncology | Modified | Apr 1, 2026 |
| Fidanacogene elaparvovec-dzkt (Beqvez) — Notification (coverage criteria) | Blue Cross Blue Shield - North Carolina | Clinical | Hematology/Oncology | Modified | Apr 1, 2026 |
| Atidarsagene autotemcel (Lenmeldy) — coverage criteria for metachromatic leukodystrophy | Blue Cross Blue Shield - North Carolina | Clinical | Hematology/Oncology | Modified | Apr 1, 2026 |
| Lifileucel (Amtagvi) — Coverage Criteria | Blue Cross Blue Shield - North Carolina | Clinical | Hematology/Oncology | Modified | Apr 1, 2026 |
| Lovotibeglogene autotemcel (Lyfgenia) — coverage and authorization criteria for sickle cell disease | Blue Cross Blue Shield - North Carolina | Clinical | Hematology/Oncology | Modified | Apr 1, 2026 |
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.
OpenPayer by Trek Health — Policy intelligence for billing and revenue cycle teams.
Coverage data is sourced from publicly available payer medical policy documents and updated as payers publish revisions. Read more about where our data comes from. Always consult the primary payer source for clinical decision-making.